血基生物记忆器用于高血糖和高脂血症监测
Kaikai Gao1,2,3,4, Bai Sun1,2,3,4, Guangdong Zhou5
1Department of Geriatric Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, China.
Materials today. Bio
|August 26, 2024
概括
这项研究引入了一种新的基于血液的生物模拟器,用于检测高血糖和高脂血症. 这种创新设备在疾病诊断和健康监测应用中显示出前景.
科学领域:
- 生物医学工程 生物医学工程
- 材料科学 材料科学 材料科学
- 神经科学是一个神经科学.
背景情况:
- 由于其类似突触的特性,memristors显示出神经形态计算的前景.
- 目前的memristor应用在很大程度上排除了生物医学领域,特别是在疾病诊断中.
- 需要新的生物传感器来检测代谢障碍,如高血糖和高脂血症.
研究的目的:
- 开发和验证一种基于血液的生物记忆器,用于体外检测高血糖和高脂血症.
- 为了研究电阻切换 (RS) 行为和生物模块的潜在机制.
- 为了证明使用memristor逻辑电路用于疾病检测的可行性.
主要方法:
- 制造了一种新的基于血液的生物共存器.
- 描述设备的电气性能,包括电阻切换 (RS) 行为.
- 对RS机制的分析,确定欧米导电和离子重排.
- 使用memristor逻辑电路构建高血糖和高脂血症检测装置.
- 通过电路模拟进行性能评估.
主要成果:
- 基于血液的生物共振器在低电压偏差下表现出极好的电阻切换 (RS) 行为.
- 欧姆导电和离子重新排列被确定为驱动RS行为的主要机制.
- 通过使用memristor逻辑电路成功构建了高血糖和高脂血症的新型检测设备.
- 电路模拟证实了这些设备用于疾病检测的可行性和潜力.
结论:
- 基于血液的生物记忆仪可用于体外检测高血糖和高脂血症.
- 这项工作为应用memristor技术在生物医学领域的疾病诊断和健康监测开辟了新的途径.
- 开发的生物模块提供了一个有前途的平台,为未来的点的护理诊断的进步.
相关概念视频
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
119
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
119
Hypoglycemia and Glucagon
218
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
218


